$0.8800
0.001010.11%
At close: -
$0.8558
-0.02-2.75%
After Hours: 4:30 PM EDT
Comments
Loading...
Latest news for Kazia Therapeutics (NASDAQ:KZIA) Stock
Kazia Therapeutics Stock (NASDAQ: KZIA)
Categories: All
Thursday, February 20, 2025
Thursday, February 06, 2025
Friday, January 31, 2025
Thursday, January 30, 2025
Friday, January 10, 2025
Tuesday, December 31, 2024
Tuesday, November 12, 2024
Monday, November 04, 2024
Friday, October 25, 2024
Friday, October 18, 2024
Thursday, October 17, 2024
Friday, October 04, 2024
Thursday, October 03, 2024
Wednesday, October 02, 2024
Monday, September 23, 2024
Thursday, September 12, 2024
Monday, July 15, 2024
Friday, July 12, 2024
- S&P 500 Rises Over 1%; Citigroup Reports Upbeat Q2 Results
- Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
- Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
- Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June
- HC Wainwright & Co. Reiterates Buy on Kazia T...
- Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Thursday, July 11, 2024
- Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- What's Going On With Kazia Therapeutics Shares Thursday?
- Kazia Therapeutics Shares Resume Trade Follow...
- US Stocks Edge Higher; Inflation Slows To 3% In June
- Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Wednesday, July 10, 2024
- Nasdaq Gains 1%; LegalZoom Shares Slide
- Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Kazia Therapeutics Shares Are Jumping Today: Successful Study For Brain Cancer Treatment
- Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher
- Kazia Therapeutics Shares Resume Trade
- Kazia Therapeutics Shares Halted On Circuit B...
- Kazia Therapeutics shares are trading higher ...
- Kazia Therapeutics Announces Phase Ii/Iii Cli...